ENTITY

Shanghai Fosun Pharmaceutical (Group) (2196 HK)

165

Analysis

Health Care • China

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.

more

Refresh

Exchange Announcement • 22 Nov 2024 18:05

Joint Announcement - Progress Update In Relation To The Pre-Conditional Privatisation Of Henlius By Fosun New Medicine By Way Of Merger By Absorption Of Henlius

Exchange Announcement • 04 Nov 2024 17:57

Overseas Regulatory Announcement - Announcement In Relation To The Acceptance Of A Subsidiary'S Drug Registration Application

Exchange Announcement • 01 Nov 2024 17:25

Next Day Disclosure Return - Share Buyback

Exchange Announcement • 30 Oct 2024 18:31

Overseas Regulatory Announcement - Announcement In Relation To The Approval For Drug Registration Of A Subsidiary

Exchange Announcement • 29 Oct 2024 19:49

Notification Letter To Registered Shareholder - New Arrangements On Dissemination Of Corporate Communications

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x